Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.

Romick-Rosendale LE, Brunner HI, Bennett MR, Mina R, Nelson S, Petri M, Kiani A, Devarajan P, Kennedy MA.

Arthritis Res Ther. 2011;13(6):R199. doi: 10.1186/ar3530. Epub 2011 Dec 7.

2.

Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.

Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.

Hum Pathol. 2001 Oct;32(10):1125-35.

PMID:
11679948
3.

Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.

Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J, Kim YG, Huh WS, Seo J, Koh EM, Cha HS.

Rheumatol Int. 2012 Jul;32(7):1877-84. doi: 10.1007/s00296-011-1887-x. Epub 2011 Mar 27.

PMID:
21442173
4.

Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.

Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y, Hanaoka M, Yamanaka H.

J Rheumatol. 2012 Jan;39(1):79-85. doi: 10.3899/jrheum.110532. Epub 2011 Nov 15.

PMID:
22089455
5.
6.

Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease.

Wen YK.

Int Urol Nephrol. 2011 Sep;43(3):801-6. doi: 10.1007/s11255-011-9911-3. Epub 2011 Feb 20.

PMID:
21336956
7.

Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis.

Hanaoka M, Gono T, Kawaguchi Y, Uchida K, Koseki Y, Katsumata Y, Kaneko H, Takagi K, Ichida H, Nitta K, Yamanaka H.

Rheumatology (Oxford). 2013 Dec;52(12):2149-57. doi: 10.1093/rheumatology/ket108. Epub 2013 Mar 5.

8.

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y.

Rheumatology (Oxford). 2008 May;47(5):702-7. doi: 10.1093/rheumatology/ken019. Epub 2008 Apr 4.

9.

Renal histological findings in adults in Jamaica.

Soyibo AK, Shah D, Barton EN, Williams W, Smith R.

West Indian Med J. 2009 Jun;58(3):265-9.

PMID:
20043536
10.

The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.

Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.

Rheumatology (Oxford). 2008 Mar;47(3):311-4. doi: 10.1093/rheumatology/kem365. Epub 2008 Jan 19.

11.

The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients.

Pagni F, Galimberti S, Goffredo P, Basciu M, Malachina S, Pilla D, Galbiati E, Ferrario F.

Nephrol Dial Transplant. 2013 Dec;28(12):3014-23. doi: 10.1093/ndt/gft272. Epub 2013 Aug 24.

12.

Classification of lupus nephritis.

Markowitz GS, D'Agati VD.

Curr Opin Nephrol Hypertens. 2009 May;18(3):220-5. Review.

PMID:
19374008
13.

Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.

do Nascimento AP, Viana Vdos S, Testagrossa Lde A, Leon EP, Borba EF, Barros RT, Bonfá E.

Arthritis Rheum. 2006 May;54(5):1568-72.

14.

Diagnostic yield of kidney biopsies performed in a suburban, satellite hospital.

Draman CR, Seman MR, Mohd Noor FS, Kelsom WM.

Saudi J Kidney Dis Transpl. 2013 Jan;24(1):178-83.

15.

The prognosis and pathogenesis of severe lupus glomerulonephritis.

Schwartz MM, Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Apr;23(4):1298-306. Epub 2007 Nov 28.

16.

Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?

Rezende GM, Viana VS, Malheiros DM, Borba EF, Silva NA, Silva C, Leon EP, Noronha IL, Bonfa E.

Lupus. 2014 Mar;23(3):255-62. doi: 10.1177/0961203313517152. Epub 2013 Dec 19.

PMID:
24356611
17.

Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.

Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Mod Rheumatol. 2016 Apr 26:1-6. [Epub ahead of print]

PMID:
27115200
18.

Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.

Lupus. 2014 Feb;23(2):159-65. doi: 10.1177/0961203313514623. Epub 2013 Dec 3.

PMID:
24300780
19.

Renal biopsy in lupus patients with low levels of proteinuria.

Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM.

J Rheumatol. 2007 Feb;34(2):332-5. Epub 2006 Dec 15.

PMID:
17183619
20.

Nephrotic syndrome in mesangial proliferative lupus nephritis.

Watanabe T.

Pediatr Int. 2007 Dec;49(6):1009-11.

PMID:
18045314
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk